7.52
Astria Therapeutics Inc (ATXS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
3.18%
35.82
|
36.99 | 29.59 | 29.01 | 28.80 |
Operating Income/Loss |
3.18%
-35.82
|
-36.99 | -29.59 | -29.01 | -28.80 |
Nonoperating Income/Loss |
15.76%
2.768
|
3.286 | 3.965 | 4.48 | 4.631 |
Income/Loss From Continuing Operations Before Tax |
1.95%
-33.05
|
-33.71 | -25.63 | -24.53 | -24.17 |
Income/Loss From Continuing Operations After Tax |
1.95%
-33.05
|
-33.71 | -25.63 | -24.53 | -24.17 |
|
1.95%
-33.05
|
-33.71 | -25.63 | -24.53 | -24.17 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.00%
58.01
|
58.01 | 0.6192 | 57.82 | 56.49 |
Diluted Average Shares |
0.00%
58.01
|
58.01 | 0.6192 | 57.82 | 56.49 |
Basic Earnings Per Share |
1.72%
-0.57
|
-0.58 | -0.44 | -0.42 | -0.43 |
Diluted Earnings Per Share |
1.72%
-0.57
|
-0.58 | -0.44 | -0.42 | -0.43 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):